thrombolytics
英
美
网络 血栓溶解药; 溶栓药物; 溶栓剂; 血栓溶解剂; 溶血栓药
双语例句
- With the increase in the morbidity of acute myocardial infarction, new thrombolytics are continually developed.
随着急性心肌梗死发病率的逐年上升，新的溶栓药物正在不断的研制中。 - Current practice in most European hospitals is to administer thrombolytics and only to refer patients for PCI if they show no evidence of reperfusion.
而目前欧洲大部分医院中的病人只有接受溶栓治疗后无再灌注证据时才接受PCI治疗。 - Objective To investigate the effects of vascular vasodilation via femoral artery puncture combined with thrombolytics on arterial ischemia of the lower extremity.
目的观察股动脉穿刺注射扩张血管及溶栓药物治疗下肢远端动脉缺血患者的临床疗效。 - Methods Vasodilator, thrombolytics and promoting microcirculatory drug were directly injected into the feeding arteries of the avascular necrotic femoral heads, under the condition of applying the blood stoppage belt at the root of thigh with pressure before the drug injection into the femoral pronator and extension arteries.
方法将扩张血管、溶栓及改善微循环的药物直接注入缺血坏死股骨头的供血动脉旋股内、外动脉。注入药物前，大腿根部用加压止血带捆绑并加压。 - Construction of Phage Single-chain Antibody-targeted Thrombolytics
噬菌体单链抗体导向溶栓剂的构建 - Lumbrokinase ( LK), as a new antithrombotic medicine, has been widely used in prevention and treatment of ischaemic cerebrovascular diseases because of its thrombolytics function.
蚓激酶（lumbrokinase，LK）作为一种新型的溶栓药物，正在广泛应用于心脑血管疾病的预防和治疗。 - A parallel randomized controlled study of efficacy and safety of reteplase as thrombolytics in patients with acute myocardial infarction
注射用瑞替普酶（派通欣）治疗急性心肌梗死有效性及安全性临床研究 - Safety of routine dose reteplase as thrombolytics in patients with acute myocardial infarction
常规剂量瑞替普酶治疗急性心肌梗死安全性分析 - Clinical effect of polarized solution containing magnesium sulfate on patients with arrhythmia due to use of thrombolytics for acute myocardial infarction
加镁极化液抑制急性心肌梗塞溶栓再灌注心律失常的临床探讨 - Evaluation and trend of thrombolytics agents
溶栓剂的评价及动向 - The application of antithrombotic drugs, including thrombolytics, anticoagulants and antiplatelets, in clinical therapy are mainly evaluated.
重点介绍抗血栓药，包括溶栓药、抗凝药及抗血小板药在目前临床应用的情况； - Objective To pool the data of randomized controlled trials ( RCT) that compared recombinant tissue-type plasminogen activator ( rt-PA) with urokinase ( UK) or streptokinase ( SK) in human pulmonary thromboembolism ( PTE) and evaluate the efficacy and safety of different thrombolytics.
目的根据现有临床研究评价重组组织型纤溶酶原激活剂（rtPA）与链激酶（SK）/尿激酶（UK）治疗肺血栓栓塞症（PTE）的有效性和安全性。